Last viewed:
NARI
Prices are updated after-hours
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
(0.0% 1d)
(-15.4% 1m)
(-42.0% 1y)
(0.0% 2d)
(0.0% 3d)
(-2.0% 7d)
(-38.48%
volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 2,236,118,212
http://www.inarimedical.com
Sec
Filling
|
Patents
| 199 employees
Inari Medical, Inc. operates as a medical device company. It develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
msa
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Inari Medical to Announce First Quarter 2024 Financial Results
Published: 2024-04-17
(Crawled : 20:00)
- globenewswire.com
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| Email alert
Add to watchlist
first
medical
financial
results
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
Published: 2024-04-11
(Crawled : 20:00)
- globenewswire.com
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| -6.79%
| O: 0.0%
H: 0.12%
C: -1.78%
report
medical
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
Published: 2024-04-02
(Crawled : 20:00)
- globenewswire.com
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| -16.2%
| O: -0.28%
H: 0.0%
C: -6.12%
medical
XPOF Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Xponential Fitness, Inc. (XPOF) Investors of Securities Fraud Class Action Lawsuit
Published: 2024-03-13
(Crawled : 19:00)
- prnewswire.com
XPOF
|
$13.15
0.31%
0.0%
540K
|
| -12.48%
| O: 0.73%
H: 2.31%
C: -1.78%
CMI
|
$287.56
-1.33%
0.0%
2.6M
|
Producer Manufacturing
| 9.01%
| O: -2.49%
H: 1.46%
C: 0.03%
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| -5.86%
| O: -0.46%
H: 2.37%
C: -0.46%
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
Published: 2024-03-12
(Crawled : 20:00)
- globenewswire.com
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| -7.59%
| O: -0.43%
H: 2.53%
C: -1.41%
clottriever
medical
registry
results
BNTX DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Published: 2024-03-12
(Crawled : 19:00)
- prnewswire.com
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| -7.59%
| O: -0.43%
H: 2.53%
C: -1.41%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
| -9.99%
| O: 0.01%
H: 0.98%
C: -1.87%
deadline
Inari Medical Investigation: Kessler Topaz Meltzer & Check, LLP Investigates The Inari Medical, Inc. (NASDAQ: NARI) for Potential Securities Violations
Published: 2024-03-12
(Crawled : 13:30)
- prnewswire.com
EAF
|
$1.51
2.03%
0.0%
3.6M
|
Producer Manufacturing
| -12.22%
| O: -0.56%
H: 8.38%
C: 4.47%
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| -8.92%
| O: 0.09%
H: 0.0%
C: -1.53%
medical
potential
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Evolv Technologies Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - EVLV
Published: 2024-03-02
(Crawled : 20:20)
- prnewswire.com
IESC
|
News
|
$115.44
-0.37%
-0.37%
120K
|
Industrial Services
| Email alert
Add to watchlist
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| Email alert
Add to watchlist
EVLV
|
News
|
$3.835
-2.67%
-2.74%
920K
|
| Email alert
Add to watchlist
MSS
|
$1.23
0.82%
0.81%
31K
|
| Email alert
Add to watchlist
MSS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maison Solutions Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - MSS
Published: 2024-03-02
(Crawled : 20:20)
- prnewswire.com
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| Email alert
Add to watchlist
IRTC
|
$112.18
0.05%
0.05%
260K
|
Health Technology
| Email alert
Add to watchlist
MSS
|
$1.23
0.82%
0.81%
31K
|
| Email alert
Add to watchlist
deadline
solutions
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
Published: 2024-03-02
(Crawled : 20:20)
- prnewswire.com
NARI
S
|
$38.58
-0.16%
-0.16%
790K
|
Health Technology
| Email alert
Add to watchlist
IRTC
|
$112.18
0.05%
0.05%
260K
|
Health Technology
| Email alert
Add to watchlist
DKS
|
News
|
$195.08
-0.07%
0.0%
720K
|
Retail Trade
| Email alert
Add to watchlist
global
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001127602-24-013158
4
2024-04-18
2024-04-16
Sell
S
1451
999782
0001127602-24-006234
4
2024-02-22
2024-02-16
Buy
A
16231
16231
0001127602-24-006234
4
2024-02-22
2024-02-16
Buy
A
14812
334016
0001127602-24-006230
4
2024-02-22
2024-02-16
Buy
A
16231
16231
0001127602-24-006230
4
2024-02-22
2024-02-16
Buy
A
14812
183361
0001127602-24-006227
4
2024-02-22
2024-02-16
Buy
A
44693
44693
0001127602-24-006227
4
2024-02-22
2024-02-16
Buy
A
40786
472696